These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 817331

  • 1. Lesions of the striatopetal dopamine and serotonin pathways: anatomy and chemistry.
    Poirier LJ, Sourkes TL.
    Pharmacol Ther B; 1976; 2(1):19-27. PubMed ID: 817331
    [No Abstract] [Full Text] [Related]

  • 2. Functional mechanism of the striatum by integration of nine types of synapses which have at least seven different transmitters.
    Hassler R.
    Int J Neurol; 1979; 13(1-4):94-116. PubMed ID: 45452
    [No Abstract] [Full Text] [Related]

  • 3. [Stereotyped behavior and the nigro-strio-nigral system].
    Arushanian EB.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
    [No Abstract] [Full Text] [Related]

  • 4. Studies on the transmitters of the afferent and efferent pathways of the striatum and their interaction in the baboon, cat and rat.
    Kim JS.
    Appl Neurophysiol; 1979; 42(1-2):62-4. PubMed ID: 36837
    [No Abstract] [Full Text] [Related]

  • 5. Central monoaminergic pathways with emphasis on their relation to the so called 'extrapyramidal motor system'.
    Fuxe K, Hökfelt T, Olson L, Ungerstedt U.
    Pharmacol Ther B; 1977; 3(2):169-210. PubMed ID: 413120
    [No Abstract] [Full Text] [Related]

  • 6. Interactions between serotonergic and catecholaminergic systems in the brain.
    Kostowski W.
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):15-24. PubMed ID: 1107968
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The striatum and substantia nigra: a commentary on their relationships.
    Dray A.
    Neuroscience; 1979 Oct; 4(10):1407-39. PubMed ID: 233319
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
    Straughan DW, James TA.
    Int J Neurol; 1979 Oct; 13(1-4):81-93. PubMed ID: 122391
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of the thalamus in the reciprocal regulation of the two nigrostriatal dopaminergic pathways.
    Chéramy A, Leviel V, Daudet F, Guibert B, Chesselet MF, Glowinski J.
    Neuroscience; 1981 Oct; 6(12):2657-68. PubMed ID: 7322356
    [No Abstract] [Full Text] [Related]

  • 16. Lesions of the nigro-neostriatal dopamine neurons or the bulbo-spinal norepinephrine and 5-hydroxytryptamine neurons in rats: action of drugs.
    Andén NE.
    Pharmacol Ther B; 1975 Oct; 1(3):371-80. PubMed ID: 772707
    [No Abstract] [Full Text] [Related]

  • 17. Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.
    Roberge AG, Poirier LJ.
    Brain Res; 1974 Aug 23; 76(3):401-12. PubMed ID: 4546739
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Electronic rotameter for quantitative evaluation of rotational behaviour in rats after unilateral lesions of the nigrostriatal dopamine system.
    Kehinde LO, Buraimoh-Igbo LA, Ude OU, Makanjuola RO.
    Med Biol Eng Comput; 1984 Jul 23; 22(4):361-6. PubMed ID: 6748772
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.